Core Viewpoint - The recent performance of Meili Tianyuan Medical Health (02373) shows significant growth in revenue and profit, indicating a positive trend in the company's financial health and operational efficiency [1] Financial Performance - For the six months ending June 30, 2025, the company reported a revenue of 1.459 billion RMB, representing a year-on-year increase of 28.2% [1] - The profit attributable to the owners of the company was 156 million RMB, which is a 34.9% increase compared to the previous year [1] - Basic earnings per share were reported at 0.68 RMB [1] Segment Performance - Revenue from beauty and health services reached 807 million RMB, marking a year-on-year growth of 29.6% [1] - Revenue from sub-health medical services surged to 150 million RMB, reflecting a remarkable year-on-year increase of 107.8% [1] Shareholder Activity - On September 9, shareholders of Meili Tianyuan Medical Health deposited shares into Galaxy Securities Hong Kong, with a market value of 536 million HKD, accounting for 6.29% of the total shares [1]
美丽田园医疗健康股东将股票存入银河证券香港 存仓市值5.36亿港元